Follow
C. David James
C. David James
Professor Emeritus, Feinberg School of Medicine, Northwestern University
Verified email at northwestern.edu - Homepage
Title
Cited by
Cited by
Year
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
RG Verhaak, KA Hoadley, E Purdom, V Wang, Y Qi, MD Wilkerson, ...
Cancer Cell 17 (1), 98-110, 2010
79262010
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
J Silber, DA Lim, C Petritsch, AI Persson, AK Maunakea, M Yu, ...
BMC medicine 6, 1-17, 2008
11332008
Genes for Epidermal Growth Factor Receptor, Transforming Growth Factor α, and Epidermal Growth Factor and Their Expression in Human Gliomas in Vivo
AJ Ekstrand, CD James, WK Cavenee, B Seliger, RF Pettersson, ...
Cancer research 51 (8), 2164-2172, 1991
8521991
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas
L Frederick, XY Wang, G Eley, CD James
Cancer research 60 (5), 1383-1387, 2000
8432000
Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.
J Reifenberger, G Reifenberger, L Liu, CD James, W Wechsler, ...
The American journal of pathology 145 (5), 1175, 1994
7921994
Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N-and/or C-terminal tails.
AJ Ekstrand, N Sugawa, CD James, VP Collins
Proceedings of the National Academy of Sciences 89 (10), 4309-4313, 1992
7821992
Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas.
N Sugawa, AJ Ekstrand, CD James, VP Collins
Proceedings of the National Academy of Sciences 87 (21), 8602-8606, 1990
7501990
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme
JS Smith, I Tachibana, SM Passe, BK Huntley, TJ Borell, N Iturria, ...
Journal of the National Cancer Institute 93 (16), 1246-1256, 2001
7472001
Sporadic Medulloblastomas Contain PTCH Mutations
C Raffel, RB Jenkins, L Frederick, D Hebrink, B Alderete, DW Fults, ...
Cancer research 57 (5), 842-845, 1997
6931997
A hierarchy of self-renewing tumor-initiating cell types in glioblastoma
R Chen, MC Nishimura, SM Bumbaca, S Kharbanda, WF Forrest, ...
Cancer cell 17 (4), 362-375, 2010
6902010
Clonal genomic alterations in glioma malignancy stages
CD James, E Carlbom, JP Dumanski, M Hansen, M Nordenskjold, ...
Cancer research 48 (19), 5546-5551, 1988
6801988
The histone H3. 3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
KM Chan, D Fang, H Gan, R Hashizume, C Yu, M Schroeder, N Gupta, ...
Genes & development 27 (9), 985-990, 2013
6692013
Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA
DA Nathanson, B Gini, J Mottahedeh, K Visnyei, T Koga, G Gomez, ...
Science 343 (6166), 72-76, 2014
5662014
Mutational inactivation of STAG2 causes aneuploidy in human cancer
DA Solomon, T Kim, LA Diaz-Martinez, J Fair, AG Elkahloun, BT Harris, ...
Science 333 (6045), 1039-1043, 2011
5472011
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin
A Lai, S Kharbanda, WB Pope, A Tran, OE Solis, F Peale, WF Forrest, ...
Journal of clinical oncology 29 (34), 4482, 2011
5242011
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
R Hashizume, N Andor, Y Ihara, R Lerner, H Gan, X Chen, D Fang, ...
Nature medicine 20 (12), 1394-1396, 2014
4662014
An overview of meningiomas
RA Buerki, CM Horbinski, T Kruser, PM Horowitz, CD James, RV Lukas
Future Oncology 14 (21), 2161-2177, 2018
4442018
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR–dependent pathway
D Guo, F Reinitz, M Youssef, C Hong, D Nathanson, D Akhavan, D Kuga, ...
Cancer discovery 1 (5), 442-456, 2011
4442011
Mechanisms of chemoresistance to alkylating agents in malignant glioma
JN Sarkaria, GJ Kitange, CD James, R Plummer, H Calvert, M Weller, ...
Clinical cancer research 14 (10), 2900-2908, 2008
4402008
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma
MD Prados, SM Chang, N Butowski, R DeBoer, R Parvataneni, H Carliner, ...
Journal of Clinical Oncology 27 (4), 579, 2009
4362009
The system can't perform the operation now. Try again later.
Articles 1–20